Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.

MLA

Zhang, Wan-Ru, et al. “Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.” Cancer Research and Treatment, vol. 53, no. 4, Oct. 2021, pp. 991–1003. EBSCOhost, https://doi.org/10.4143/crt.2020.1298.

APA

Zhang, W.-R., Du, Y.-Y., Guo, C.-Y., Zhou, H.-X., Lin, J.-Y., Meng, X.-H., Mo, H.-Y., & Luo, D.-H. (2021). Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer Research and Treatment, 53(4), 991–1003. https://doi.org/10.4143/crt.2020.1298

Chicago

Zhang, Wan-Ru, Yu-Yun Du, Chun-Yan Guo, Han-Xing Zhou, Jie-Yi Lin, Xiao-Han Meng, Hao-Yuan Mo, and Dong-Hua Luo. 2021. “Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.” Cancer Research and Treatment 53 (4): 991–1003. doi:10.4143/crt.2020.1298.